Sign up to save your podcasts
Or
Share Guilherme Weigert / Conexa Saude on pioneering product-led growth in telemedicine, scaling Conexa from 20 to ~600 employees and the future of health in Brazil
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Guilherme Weigert / Conexa Saude on pioneering product-led growth in telemedicine, scaling Conexa from 20 to ~600 employees and the future of health in Brazil
November 21: For this episode of the J Curve I am thrilled to bring you my conversation with Guilherme Weigert, founder and CEO at Conexa Saude, Brazil's leading telemedicine and digital health platform that manages over 20M lives and that has recently raised ~$40M Series C from the likes of General Atlantic, Goldman Sachs and Igah Ventures.
In today's episode we will learn:
1. When, why and how to pivot a healthcare business: Conexa's experience
2. What were the most challenging aspects of managing Conexa's rapid growth during Covid-19? Spoiler alert: it had everything to do with hiring.
3. How to build a sustainable Product-Led Growth Strategy: Conexa's playbook
4. Why Data Science is the ultimate competitive edge and value driver for Conexa?
5. What are the unique challenges of disrupting the healthcare market in Brazil?
View all episodes
By Olga MaslikhovaNovember 21: For this episode of the J Curve I am thrilled to bring you my conversation with Guilherme Weigert, founder and CEO at Conexa Saude, Brazil's leading telemedicine and digital health platform that manages over 20M lives and that has recently raised ~$40M Series C from the likes of General Atlantic, Goldman Sachs and Igah Ventures.
In today's episode we will learn:
1. When, why and how to pivot a healthcare business: Conexa's experience
2. What were the most challenging aspects of managing Conexa's rapid growth during Covid-19? Spoiler alert: it had everything to do with hiring.
3. How to build a sustainable Product-Led Growth Strategy: Conexa's playbook
4. Why Data Science is the ultimate competitive edge and value driver for Conexa?
5. What are the unique challenges of disrupting the healthcare market in Brazil?